BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23458233)

  • 21. Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes.
    Aghayan DL; Kalinowski P; Kazaryan AM; Fretland ÅA; Sahakyan MA; Røsok BI; Pelanis E; Bjørnbeth BA; Edwin B
    World J Surg Oncol; 2019 Sep; 17(1):156. PubMed ID: 31484583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.
    Verboom MC; Kloth JSL; Swen JJ; van der Straaten T; Bovée JVMG; Sleijfer S; Reyners AKL; Mathijssen RHJ; Guchelaar HJ; Steeghs N; Gelderblom H
    Eur J Cancer; 2017 Nov; 86():226-232. PubMed ID: 29054076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and predictors of synchronous liver metastases in patients with gastrointestinal stromal tumors (GISTs).
    Gaitanidis A; Alevizakos M; Tsaroucha A; Simopoulos C; Pitiakoudis M
    Am J Surg; 2018 Sep; 216(3):492-497. PubMed ID: 29690997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive surgery for liver metastases from gastrointestinal stromal tumors.
    Shima Y; Horimi T; Ishikawa T; Ichikawa J; Okabayashi T; Nishioka Y; Hamada M; Shibuya Y; Ishii T; Ito M
    J Hepatobiliary Pancreat Surg; 2003; 10(1):77-80. PubMed ID: 12827476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
    Tsyganova IV; Anurova OA; Mazurenko NN
    Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment strategy for recurrent and metastatic gastrointestinal stromal tumors].
    Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):309-11. PubMed ID: 24760634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor volume as a prognostic factor for sarcomatosis.
    Bilimoria MM; Holtz DJ; Mirza NQ; Feig BW; Pisters PW; Patel S; Pollock RE; Benjamin RS; Papadopoulos NE; Plager C; Murphy A; Griffin JR; Burgess MA; Hunt KK
    Cancer; 2002 May; 94(9):2441-6. PubMed ID: 12015769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
    Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP
    Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal Stromal Tumours of the Rectum - Evaluating the National Registry Data with Respect to its Use in Clinical Practice.
    Svatoň R; Kala Z; Kysela P; Procházka V; Eid M; Andrašina T; Poredská K; Strenková J; Chloupková R; Kunovsky L
    Klin Onkol; 2019; 32(2):117-123. PubMed ID: 30995851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).
    Ye YJ; Gao ZD; Poston GJ; Wang S
    Eur J Surg Oncol; 2009 Aug; 35(8):787-92. PubMed ID: 19185444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
    Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs).
    Gaitanidis A; El Lakis M; Alevizakos M; Tsaroucha A; Pitiakoudis M
    Langenbecks Arch Surg; 2018 Aug; 403(5):599-606. PubMed ID: 29855800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy.
    Qiu HB; Zhou ZG; Feng XY; Liu XC; Guo J; Ma MZ; Chen YB; Sun XW; Zhou ZW
    Medicine (Baltimore); 2018 Jan; 97(2):e9097. PubMed ID: 29480823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy.
    Sakakura C; Hagiwara A; Soga K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yamaoka N; Sagara Y; Yamagishi H
    World J Gastroenterol; 2006 May; 12(17):2793-7. PubMed ID: 16718773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case.
    Iesari S; Mocchegiani F; Nicolini D; Benedetti Cacciaguerra A; Coletta M; Montalti R; Mandolesi A; Lerut J; Vivarelli M
    Am J Transplant; 2019 Oct; 19(10):2939-2943. PubMed ID: 30943317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resection Combined with TKI Therapy for Resectable Liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China.
    Chen Q; Li C; Yang H; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Cai J; Zhou J
    J Gastrointest Surg; 2020 Jun; 24(6):1330-1341. PubMed ID: 31187396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors.
    Kobayashi K; Gupta S; Trent JC; Vauthey JN; Krishnamurthy S; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; McRae SE; Hicks ME
    Cancer; 2006 Dec; 107(12):2833-41. PubMed ID: 17096432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.
    Zaydfudim V; Okuno SH; Que FG; Nagorney DM; Donohue JH
    J Surg Res; 2012 Oct; 177(2):248-54. PubMed ID: 22831567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors.
    Hakimé A; Le Cesne A; Deschamps F; Farouil G; Boudabous S; Aupérin A; Domont J; Debaere T
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):132-9. PubMed ID: 23589213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
    Zhu J; Yang Y; Zhou L; Jiang M; Hou M
    BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.